United Therapeutics price target lowered to $420 from $430 at Leerink [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
Leerink analyst Roanna Ruiz lowered the firm's price target on United Therapeutics ( UTHR ) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics' Q4 earnings brought clarity on the outlook for the base commercial business and Tyvaso's future growth trajectory, suggesting that gross-to-net impact from recent contracting efforts for the Tyvaso franchise should be largely baked in going forward, the analyst tells investors in a research note. The firm adds that Q4 could represent a “new base” for demand-driven Tyvaso growth moving into 2025. Leerink remains positive on Tyvaso longer-term growth trajectory. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ratings fro
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- 2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off [Yahoo! Finance]Yahoo! Finance
- Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System [Yahoo! Finance]Yahoo! Finance
- For Patients Needing Transplants, Hope Arrives on Tiny Hooves [The New York Times]The New York Times
- United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025Business Wire
- United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
UTHR
Earnings
- 2/26/25 - Beat
UTHR
Sec Filings
- 3/25/25 - Form 4
- 3/24/25 - Form 144
- 3/20/25 - Form 4
- UTHR's page on the SEC website